Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM)
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 8,000 | |||
25 mg | 在庫あり | ¥ 16,500 | |||
50 mg | 在庫あり | ¥ 22,500 | |||
100 mg | 在庫あり | ¥ 35,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM) |
ターゲット&IC50 | CTD:4-10 µM |
In vitro | DRB can inhibit HIV transcription (IC50 = ~4 μM) by targeting elongation enhanced by the HIV-encoded transactivator Tat[1]. |
分子量 | 319.14 |
分子式 | C12H12Cl2N2O4 |
CAS No. | 53-85-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.19 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DRB 53-85-0 Microbiology/Virology Proteases/Proteasome HIV Protease 5,6-Dichlorobenzimidazole riboside inhibit Inhibitor CDK Cyclin dependent kinase inhibitor